4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-23-000076
Chief Scientific Officer sold 13,800 shares at $5.03 ($69,370)
From the SEC's structured data for this filing
Trades in this filing
Mor George Adi · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Sale : show line 1 in the form | −7,700 | $5.03 | $38,706 | 317,075 | D |
| 2023-01-03 | Sale : show line 2 in the form | −6,100 | $5.03 | $30,663 | 251,147 | I |
| Open-market sales · 13,800 sh · avg $5.03 · $69,370 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-15 | Grant or award : show line 3 in the form Option to Purchase American Depositary Shares | +131,698 | 131,698 | D |
| 2016-10-28 | Grant or award : show line 4 in the form Option to Purchase American Depositary Shares | +33,725 | 33,725 | I |
Loading xslF345X03/ownership.xml…